These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6733008)

  • 21. Effect of rifampicin on metoprolol and antipyrine kinetics.
    Bennett PN; John VA; Whitmarsh VB
    Br J Clin Pharmacol; 1982 Mar; 13(3):387-91. PubMed ID: 7059439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spironolactone--a weak enzyme inducer in man.
    Taylor SA; Rawlins MD; Smith SE
    J Pharm Pharmacol; 1972 Jul; 24(7):578-9. PubMed ID: 4403853
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of chlorpromazine on drug metabolism.
    Stevenson IH; O'Malley K; Turnbull MJ; Ballinger BR
    J Pharm Pharmacol; 1972 Jul; 24(7):577-8. PubMed ID: 4403852
    [No Abstract]   [Full Text] [Related]  

  • 24. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Harmatz JS; Shader RI
    J Pharmacol Exp Ther; 1982 Jan; 220(1):120-6. PubMed ID: 7053408
    [No Abstract]   [Full Text] [Related]  

  • 25. Kinetic studies on rifampicin. III. Effect of phenobarbital on the half-life of the antibiotic.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Nicolis FB
    Tijdschr Gastroenterol; 1974; 17(3):151-8. PubMed ID: 4454053
    [No Abstract]   [Full Text] [Related]  

  • 26. [Influence of rifampicin on the metabolic clearance of galactose and antipyrine as compared with hexobarbital].
    Zilly W; Wernze H; Buchenau D; Breimer DD; Richter E
    Verh Dtsch Ges Inn Med; 1975; 81():1677-80. PubMed ID: 1227056
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modification of the action of drugs by inhibition of their metabolism].
    Park BK; Breckenridge AM; Ohnhaus EE
    Recenti Prog Med; 1979 Sep; 67(3):313-45. PubMed ID: 42953
    [No Abstract]   [Full Text] [Related]  

  • 28. Enzyme induction of renal transport mechanism by rifampicin in man?
    Brockmeyer NH; Heidemann H; Ohnhaus EE
    Pharmacol Ther; 1987; 33(1):205-7. PubMed ID: 3114773
    [No Abstract]   [Full Text] [Related]  

  • 29. Divergent effects of different enzyme-inducing agents on endogenous and exogenous testosterone.
    Bammel A; van der Mee K; Ohnhaus EE; Kirch W
    Eur J Clin Pharmacol; 1992; 42(6):641-4. PubMed ID: 1623905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A re-evaluation of intersubject variation in enzyme induction in man.
    Branch RA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):104-10. PubMed ID: 455871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pesticide exposure on human microsomal enzyme induction.
    Uppal R; Sharma PR; Chaudhury RR
    Hum Toxicol; 1982 Mar; 1(2):155-8. PubMed ID: 7173896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in D-glucaric acid excretion in relationship to alterations in the rate of antipyrine metabolism in man.
    Hunter J; Burnham WR; Chasseaud LF; Down W
    Biochem Pharmacol; 1974 Sep; 23(17):2480-3. PubMed ID: 4429583
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of rifampin administration on the disposition of fexofenadine.
    Hamman MA; Bruce MA; Haehner-Daniels BD; Hall SD
    Clin Pharmacol Ther; 2001 Mar; 69(3):114-21. PubMed ID: 11240975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
    Chailleux E; Ordronneau J; Le Normand Y; Kergueris MF; Larousse C
    Rev Fr Mal Respir; 1980; 8(3):219-24. PubMed ID: 7187065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme induction in the elderly: effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone.
    Dilger K; Hofmann U; Klotz U
    Clin Pharmacol Ther; 2000 May; 67(5):512-20. PubMed ID: 10824630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicin.
    Bergrem H; Refvem OK
    Proc Eur Dial Transplant Assoc; 1983; 19():552-7. PubMed ID: 6878255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipyrine metabolism in lung cancer patients and their relatives.
    Radzikowska E; Gazdzik W; Rowińska-Zakrzewska E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():297-308. PubMed ID: 9337547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme induction with rifampicin; lipoproteins and drug binding to alpha 1-acid glycoprotein.
    Feely J; Clee M; Pereira L; Guy E
    Br J Clin Pharmacol; 1983 Aug; 16(2):195-7. PubMed ID: 6615694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of antipyrine clearance and induction of antipyrine 4-hydroxylation by 3-methylcholanthrene in rats [proceedings].
    Kroos-De Haan MA; Noordhoek J
    Br J Pharmacol; 1980 Jan; 68(1):120P. PubMed ID: 7357140
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rifampicin-induced nonresponsiveness to corticosteroid treatment in systemic lupus erythematosus: a case report].
    Itoh H; Fujihira T; Harada S; Kido M; Kajiki A; Nakashima Y; Kuroiwa A
    Kekkaku; 1984 Apr; 59(4):303-8. PubMed ID: 6748459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.